BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 14642176)

  • 1. [Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients].
    Xu LP; Huang XJ; Guo NL; Ren HY; Zhang YC; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):407-9. PubMed ID: 14642176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between copies of cytomegalovirus in plasma and cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation].
    Chen YH; Zhao XS; Liu KY; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang Y; Zhao T; Zhao XT; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1540-3. PubMed ID: 19953881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
    Chen H; Liu KY; Xu LP; Liu DH; Chen YH; Zhao XS; Yu L; Han W; Zhang XH; Wang Y; Chen Y; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):77-81. PubMed ID: 19563015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Mori T; Mori S; Kanda Y; Yakushiji K; Mineishi S; Takaue Y; Gondo H; Harada M; Sakamaki H; Yajima T; Iwao Y; Hibi T; Okamoto S
    Bone Marrow Transplant; 2004 Feb; 33(4):431-4. PubMed ID: 14676775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients.
    Limaye AP; Huang ML; Leisenring W; Stensland L; Corey L; Boeckh M
    J Infect Dis; 2001 Feb; 183(3):377-82. PubMed ID: 11133368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of quantitative competitive polymerase chain reaction-enzyme-linked immunosorbent assay with LightCycler-based polymerase chain reaction for measuring cytomegalovirus DNA in patients after hematopoietic stem cell transplantation.
    Pumannova M; Roubalova K; Vitek A; Sajdova J
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):115-20. PubMed ID: 16406183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
    Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
    Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
    Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
    J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance.
    Bilgrami S; Aslanzadeh J; Feingold JM; Bona RD; Clive J; Dorsky D; Edwards RL; Tutschka PJ
    Bone Marrow Transplant; 1999 Jul; 24(1):69-73. PubMed ID: 10435738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cytomegalovirus in liver transplant biopsies. A comparison of light microscopy, immunohistochemistry, duplex PCR and nested PCR.
    Brainard JA; Greenson JK; Vesy CJ; Tesi RJ; Papp AC; Snyder PJ; Western L; Prior TW
    Transplantation; 1994 Jun; 57(12):1753-7. PubMed ID: 8016881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
    Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L
    Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation.
    Mori T; Okamoto S; Watanabe R; Yajima T; Iwao Y; Yamazaki R; Nakazato T; Sato N; Iguchi T; Nagayama H; Takayama N; Hibi T; Ikeda Y
    Bone Marrow Transplant; 2002 May; 29(9):777-82. PubMed ID: 12040476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytomegaloviral infection in patients with hemoblastoses].
    Savchenko VG; Troitskaia VV; Misiurin AV; Parovichnikova VN; Isaev VG; Mendeleeva LP; Liubimova LS; Demidova IA; Aksenova EV; Filatov FP
    Ter Arkh; 2003; 75(7):52-8. PubMed ID: 12934482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cytomegalovirus infection after peripheral blood stem cell transplantation.
    Sakuma H; Hosoya M; Kanno H; Kikuta A; Konno K; Kawano Y; Takaue Y; Shigeta S; Suzuki H
    Bone Marrow Transplant; 1997 Jan; 19(1):49-53. PubMed ID: 9012931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.